Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial

Caitlin C. Murphy, Sally W. Vernon, Nicole M. Haddock, Melissa L. Anderson, Jessica Chubak, Beverly B. Green

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective: Few studies use longitudinal data to identify predictors of colorectal cancer screening (CRCS). We examined predictors of (1) initial CRCS during the first year of a randomized trial, and (2) repeat CRCS during the second year of the trial among those that completed FOBT in Year 1. Methods: The sample comprised 1247 participants of the Systems of Support to Increase Colorectal Cancer Screening (SOS) Trial (Group Health Cooperative, August 2008 to November 2011). Potential predictors of CRCS were identified with logistic regression and included sociodemographics, health history, and validated scales of psychosocial constructs. Results: Prior CRCS (OR 2.64, 95% CI 1.99-3.52) and intervention group (Automated: OR 2.06 95% CI 1.43-2.95; Assisted: OR 4.03, 95% CI 2.69-6.03; Navigated: OR 5.64, 95% CI 3.74-8.49) were predictors of CRCS completion at Year 1. For repeat CRCS at Year 2, prior CRCS at baseline (OR 1.97, 95% CI 1.25-3.11), intervention group (Automated: OR 9.27, 95% CI 4.56-18.82; Assisted: OR 11.17, 95% CI 5.44-22.94; Navigated: OR 13.10, 95% CI 6.33-27.08), and self-efficacy (OR 1.32, 95% CI 1.00-1.73) were significant predictors. Conclusion: Self-efficacy and prior CRCS are important predictors of future screening behavior. CRCS completion increased when access barriers were removed through interventions.

Original languageEnglish (US)
Pages (from-to)123-130
Number of pages8
JournalPreventive Medicine
Volume66
DOIs
StatePublished - Jan 1 2014

Fingerprint

Early Detection of Cancer
Colorectal Neoplasms
Randomized Controlled Trials
Self Efficacy
Health
Longitudinal Studies
Logistic Models

Keywords

  • Behavioral intervention research
  • Cancer screening
  • Colorectal cancer
  • Longitudinal study

ASJC Scopus subject areas

  • Epidemiology
  • Public Health, Environmental and Occupational Health

Cite this

Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. / Murphy, Caitlin C.; Vernon, Sally W.; Haddock, Nicole M.; Anderson, Melissa L.; Chubak, Jessica; Green, Beverly B.

In: Preventive Medicine, Vol. 66, 01.01.2014, p. 123-130.

Research output: Contribution to journalArticle

Murphy, Caitlin C. ; Vernon, Sally W. ; Haddock, Nicole M. ; Anderson, Melissa L. ; Chubak, Jessica ; Green, Beverly B. / Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. In: Preventive Medicine. 2014 ; Vol. 66. pp. 123-130.
@article{8845c8acd7264beea246e1f48e891b54,
title = "Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial",
abstract = "Objective: Few studies use longitudinal data to identify predictors of colorectal cancer screening (CRCS). We examined predictors of (1) initial CRCS during the first year of a randomized trial, and (2) repeat CRCS during the second year of the trial among those that completed FOBT in Year 1. Methods: The sample comprised 1247 participants of the Systems of Support to Increase Colorectal Cancer Screening (SOS) Trial (Group Health Cooperative, August 2008 to November 2011). Potential predictors of CRCS were identified with logistic regression and included sociodemographics, health history, and validated scales of psychosocial constructs. Results: Prior CRCS (OR 2.64, 95{\%} CI 1.99-3.52) and intervention group (Automated: OR 2.06 95{\%} CI 1.43-2.95; Assisted: OR 4.03, 95{\%} CI 2.69-6.03; Navigated: OR 5.64, 95{\%} CI 3.74-8.49) were predictors of CRCS completion at Year 1. For repeat CRCS at Year 2, prior CRCS at baseline (OR 1.97, 95{\%} CI 1.25-3.11), intervention group (Automated: OR 9.27, 95{\%} CI 4.56-18.82; Assisted: OR 11.17, 95{\%} CI 5.44-22.94; Navigated: OR 13.10, 95{\%} CI 6.33-27.08), and self-efficacy (OR 1.32, 95{\%} CI 1.00-1.73) were significant predictors. Conclusion: Self-efficacy and prior CRCS are important predictors of future screening behavior. CRCS completion increased when access barriers were removed through interventions.",
keywords = "Behavioral intervention research, Cancer screening, Colorectal cancer, Longitudinal study",
author = "Murphy, {Caitlin C.} and Vernon, {Sally W.} and Haddock, {Nicole M.} and Anderson, {Melissa L.} and Jessica Chubak and Green, {Beverly B.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.ypmed.2014.06.013",
language = "English (US)",
volume = "66",
pages = "123--130",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial

AU - Murphy, Caitlin C.

AU - Vernon, Sally W.

AU - Haddock, Nicole M.

AU - Anderson, Melissa L.

AU - Chubak, Jessica

AU - Green, Beverly B.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective: Few studies use longitudinal data to identify predictors of colorectal cancer screening (CRCS). We examined predictors of (1) initial CRCS during the first year of a randomized trial, and (2) repeat CRCS during the second year of the trial among those that completed FOBT in Year 1. Methods: The sample comprised 1247 participants of the Systems of Support to Increase Colorectal Cancer Screening (SOS) Trial (Group Health Cooperative, August 2008 to November 2011). Potential predictors of CRCS were identified with logistic regression and included sociodemographics, health history, and validated scales of psychosocial constructs. Results: Prior CRCS (OR 2.64, 95% CI 1.99-3.52) and intervention group (Automated: OR 2.06 95% CI 1.43-2.95; Assisted: OR 4.03, 95% CI 2.69-6.03; Navigated: OR 5.64, 95% CI 3.74-8.49) were predictors of CRCS completion at Year 1. For repeat CRCS at Year 2, prior CRCS at baseline (OR 1.97, 95% CI 1.25-3.11), intervention group (Automated: OR 9.27, 95% CI 4.56-18.82; Assisted: OR 11.17, 95% CI 5.44-22.94; Navigated: OR 13.10, 95% CI 6.33-27.08), and self-efficacy (OR 1.32, 95% CI 1.00-1.73) were significant predictors. Conclusion: Self-efficacy and prior CRCS are important predictors of future screening behavior. CRCS completion increased when access barriers were removed through interventions.

AB - Objective: Few studies use longitudinal data to identify predictors of colorectal cancer screening (CRCS). We examined predictors of (1) initial CRCS during the first year of a randomized trial, and (2) repeat CRCS during the second year of the trial among those that completed FOBT in Year 1. Methods: The sample comprised 1247 participants of the Systems of Support to Increase Colorectal Cancer Screening (SOS) Trial (Group Health Cooperative, August 2008 to November 2011). Potential predictors of CRCS were identified with logistic regression and included sociodemographics, health history, and validated scales of psychosocial constructs. Results: Prior CRCS (OR 2.64, 95% CI 1.99-3.52) and intervention group (Automated: OR 2.06 95% CI 1.43-2.95; Assisted: OR 4.03, 95% CI 2.69-6.03; Navigated: OR 5.64, 95% CI 3.74-8.49) were predictors of CRCS completion at Year 1. For repeat CRCS at Year 2, prior CRCS at baseline (OR 1.97, 95% CI 1.25-3.11), intervention group (Automated: OR 9.27, 95% CI 4.56-18.82; Assisted: OR 11.17, 95% CI 5.44-22.94; Navigated: OR 13.10, 95% CI 6.33-27.08), and self-efficacy (OR 1.32, 95% CI 1.00-1.73) were significant predictors. Conclusion: Self-efficacy and prior CRCS are important predictors of future screening behavior. CRCS completion increased when access barriers were removed through interventions.

KW - Behavioral intervention research

KW - Cancer screening

KW - Colorectal cancer

KW - Longitudinal study

UR - http://www.scopus.com/inward/record.url?scp=84903884348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903884348&partnerID=8YFLogxK

U2 - 10.1016/j.ypmed.2014.06.013

DO - 10.1016/j.ypmed.2014.06.013

M3 - Article

VL - 66

SP - 123

EP - 130

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

ER -